SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

Inhibrx Q3 EPS $(0.77) Misses $(0.60) Estimate, Sales $5.90M Beat $1.00M Estimate

Inhibrx (NASDAQ:INBX) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.60) by 28.33 percent. This is a 30.63 percent increase over losses of $(1.11) per share from the

· 11/13/2020 16:18
Inhibrx (NASDAQ:INBX) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.60) by 28.33 percent. This is a 30.63 percent increase over losses of $(1.11) per share from the same period last year. The company reported quarterly sales of $5.90 million which beat the analyst consensus estimate of $1.00 million by 490.10 percent. This is a 384.09 percent increase over sales of $1.22 million the same period last year.